What is the name of the blood test that determines the gender of a baby, Non-Invasive Prenatal Test (NIPT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Blood Test for Baby Gender Determination

The blood test used to determine a baby's gender is called Non-Invasive Prenatal Testing (NIPT) or Non-Invasive Prenatal Screening (NIPS), which analyzes cell-free fetal DNA in maternal blood. 1, 2

How NIPT Works for Sex Determination

NIPT detects fetal sex by analyzing cell-free DNA (cfDNA) from the placenta that circulates in maternal blood, which comprises approximately 10-15% of the total cell-free DNA in maternal plasma. 2, 3

  • The test can be performed after 9-10 weeks of gestation when sufficient fetal DNA is present in maternal circulation 2
  • Advanced laboratory techniques including Next Generation Sequencing (NGS) and digital PCR allow highly sensitive detection of fetal genetic material 3, 4
  • The test identifies the presence or absence of Y chromosome sequences to determine fetal sex 5, 3

Clinical Accuracy and Reliability

NIPT for fetal sex determination is highly accurate, with the American College of Obstetricians and Gynecologists recommending it as a reliable non-invasive alternative to invasive testing, particularly for pregnancies at risk of sex-linked genetic disorders. 2

  • Fetal sex determination by NIPT is relatively accurate, though rare discordant results between NIPT sex designation and physical examination at birth can occur 1
  • In research studies, fetal sex was diagnosed correctly in all successful early tests, with results confirmed at delivery 6, 5

Important Limitations and Considerations

NIPT is a screening test, not a diagnostic test, and approximately 1% of initial samples result in "no-call" results, most commonly due to insufficient fetal fraction. 1, 2, 7

Factors Affecting Test Success:

  • Maternal obesity is strongly associated with low fetal fraction and may result in test failure in up to 20% of women with high BMI 2
  • Maternal anticoagulant use and autoimmune disorders are associated with higher no-call rates 1
  • Multiple gestations or vanishing twin syndrome can affect fetal fraction measurements and interpretation 2

Management of No-Call Results:

  • If a no-call result occurs at 9 weeks, repeat testing at a slightly later gestational age provides a result in approximately 75-80% of cases 2
  • The American College of Obstetricians and Gynecologists recommends offering diagnostic testing to individuals with persistent no-call results 1, 2

Clinical Context and Counseling

NIPT for fetal sex determination should be performed in the context of appropriate pre-test and post-test genetic counseling. 2, 7

  • Patients should understand that while highly accurate, NIPT is a screening test and any abnormal or uncertain results should be confirmed with diagnostic testing 2, 7
  • The test is particularly valuable for pregnancies at risk of sex-linked genetic disorders such as Wiskott-Aldrich disease, where early sex determination guides clinical management 5
  • Blood chromosome analysis is recommended if sex designation by NIPT is discordant with physical examination findings at birth 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Non-Invasive Prenatal Testing for Fetal Sex Determination

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Non-invasive Prenatal Testing Using Fetal DNA.

Molecular diagnosis & therapy, 2019

Research

Non invasive prenatal testing (NIPT) for common aneuploidies and beyond.

European journal of obstetrics, gynecology, and reproductive biology, 2021

Guideline

Non-Invasive Prenatal Testing and Fetal Echocardiography Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.